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Abstract
Background: Aspartyl-(Asparaginyl)-b-Hydroxylase (AAH) is a hydroxylating enzyme that promotes cell motility by
enhancing Notch-Jagged-HES-1 signaling. Ethanol impaired cerebellar neuron migration during development is
associated with reduced expression of AAH.
Methods: To further characterize the role of AAH in relation to cerebellar development, structure, and function, we
utilized an in vivo model of early postnatal (P2) intracerebro-ventricular gene delivery to silence AAH with small
interfering RNA (siAAH), or over-express it with recombinant plasmid DNA (pAAH). On P20, we assessed cerebellar
motor function by rotarod testing. Cerebella harvested on P21 were used to measure AAH, genes/proteins that
mediate AAH’s downstream signaling, i.e. Notch-1, Jagged-1, and HES-1, and immunoreactivity corresponding to
neuronal and glial elements.
Results: The findings demonstrated that: 1) siAAH transfection impaired motor performance and blunted cerebellar
foliation, and decreased expression of neuronal and glial specific genes; 2) pAAH transfection enhanced motor
performance and increased expression of neuronal and glial cytoskeletal proteins; and 3) alterations in AAH
expression produced similar shifts in Notch-1, Jagged-1, and HES-1 protein or gene expression.
Conclusions: The results support our hypothesis that AAH is an important mediator of cerebellar development
and function, and link AAH expression to Notch signaling pathways in the developing brain.
Background
Aspartyl-(asparaginyl)-b-hydroxylase (AAH) is an ~86
kD Type 2 transmembrane protein and member of the
a-ketoglutarate-dependent dioxygenase family that
includes prolyl-3, prolyl-4, and lysyl hydroxylases [1-3].
AAH’s carboxyl region can be proteolytically cleaved to
generate ~52 kD or ~56 kD catalytically active fragments
[1,3,4]. Site-directed mutagenesis studies demonstrated
that the
675His residue present in the C-terminal frag-
ment is essential for catalytic activity [1,5]. AAH catalyzes
post-translational hydroxylation of b carbons of specific
aspartate and asparagine residues in epidermal growth
factor (EGF)-like domains [6] of proteins such as
Notch and Jagged [5,7], which have known roles in
cell growth, differentiation, and neuronal migration
during development [8,9], and in extracellular matrix
molecules, such as tenascin [2], which mediate adhesion,
motility, and cell process extension [10-12]. Correspond-
ingly, previous studies showed that Jagged, the ligand for
Notch [13,14], is indeed a substrate for AAH hydroxyla-
tion [7], and that AAH is capable of physically interacting
with both Notch and Jagged [15]. Moreover, over-expres-
sion of AAH results in increased nuclear translocation
and accumulation of Notch, and activation of Notch’s
downstream target genes, including Hairy and Enhancer
of Split 1 (HES-1) [15].
A direct role for AAH in cell motility and invasion was
demonstrated by the findings that: 1) over-expression of
AAH by transfection with recombinant plasmid DNA
increases cell motility; 2) inhibition of AAH via gene
silencing with small interfering (si) RNA duplexes
reduces cell motility; and 3) inhibition of signaling
pathways required for AAH expression and function
impairs cell motility [15-21]. The AAH gene is regulated
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ing through insulin receptor substrate (IRS)-dependent
pathways that activate Erk MAPK and phosphatidylino-
sitol-3-kinase (PI3 kinase)-Akt [15,17,19]. However,
AAH is also regulated by post-translational mechan-
isms, since chemical inhibition of glycogen synthase
kinase 3b (GSK-3b) by LiCl or transfection with
si-GSK-3b [16,19] increased AAH protein without
altering its mRNA levels, and over-expression of cataly-
tically active GSK-3b increased AAH phosphorylation
and reduced AAH protein expression [16].
Previous studies demonstrated that ethanol inhibits
insulin and IGF signaling in immature neuronal cells
[22-26], and that chronic in utero exposure to ethanol
causes fetal alcohol spectrum disorders (FASD). FASD is
associated with impaired cerebellar development includ-
ing hypoplasia, disordered neuronal migration, insulin
and IGF resistance, and reduced AAH expression
[18,24-27]. Ethanol’si n h i b i t o r ye f f e c t so nA A Ha r e
mediated at transcription and post-translation levels [18].
Since insulin and IGF signaling pathways mediate cere-
bellar growth and development [28], and AAH is a down-
stream target of insulin and IGF stimulation [15,19], we
hypothesize that in FASD, ethanol impaired cerebellar
development is mediated, in part, by inhibition of AAH
expression and/or function. Herein, we used in vivo mod-
els to determine if inhibition of AAH is sufficient to
cause some of the functional and neuro-developmental
abnormalities observed in FASD. The strategy used was
to transfect immature brains with siRNA targeting AAH,
or recombinant plasmid carrying the full length AAH
cDNA, and examine the long-term consequences in
terms of function, structure, and gene expression in the
brain. We focused our investigations on the cerebellum
because this structure: 1) develops mainly in the early
postnatal period; 2) is a primary target of ethanol-
mediated neurotoxicity; and 3) exhibits impaired AAH
expression in experimental models of FASD [18].
Methods
Gene delivery model
Two-day-old (P2) Long Evans rat pups were given a sin-
gle intracerebroventricular injection of small interfering
RNA duplexes (siRNA) that targeted AAH (siAAH)
[ASPH NM_001009716] or no specific sequences
(scrambled; siScr) [NM D-00121001-20], or recombinant
plasmid DNA containing the complete coding sequence
of human AAH (pAAH), or Green fluorescent protein
(pGFP). The cDNAs were ligated into the pcDNA3.1 vec-
tor (Invitrogen, Carlsbad, CA) in which gene expression
was under the control of a CMV promoter. Supercoiled
plasmid DNA was purified using endotoxin-free columns
(Qiagen Inc., Valencia, CA). For each animal, 10 μgo f
recombinant plasmid DNA or 0.4 nmol siRNA were
complexed with 10 μl of Dharmafect reagent (Dharma-
con, Inc., Chicago, IL), and injected into the right lateral
v e n t r i c l eu s i n gaH a m i l t o ns y r i n g ew i t ha2 6 - g a u g en e e -
dle as previously described [29,30]. All animals survived
the procedure, and there were no consequential aberrant
behaviors or adverse effects such as failure to thrive, poor
grooming, reduced physical activity, or weight loss. The
rats were subjected to rotarod testing on P20, and sacri-
ficed on P21 (N = 8 per group). However, several rats
were sacrificed on P35 for longer observation (N = 6 per
group). Cerebella were divided in the mid-sagittal plane.
One half was fixed in Histochoice (Amresco, Solon, OH)
and embedded in paraffin. Histological sections were
stained with Luxol fast blue, hematoxylin and eosin
(LHE) to detect morphological abnormalities. The other
half was snap-frozen in a dry ice/methanol bath and
stored at -80°C for later mRNA and protein studies. Our
experimental protocol was approved by the Institutional
Animal Care and Use Committee at Lifespan-Rhode
Island Hospital, and it conforms to the guidelines set by
the National Institutes of Health.
Rotarod testing
We used rotarod testing to assess long-term effects on
motor function [31] resulting from the siAAH or pAAH
treatments. On P19, rats were trained to remain
balanced on the rotating Rotamex-5 apparatus (Colum-
bus Instruments) at 1-5 rpm. On P20, rats (N = 8-10
per group) were administered 10 trials at incremental
speeds up to 10 rpm, with 10 minutes rest between
each trial. The latency to fall was automatically detected
and recorded with photocells placed over the rod. How-
ever, trials were stopped after 30 seconds to avoid exer-
cise fatigue. Data from trials 1-3 (2-5 rpm), 4-7 (5-7
rpm), and 8-10 (8-10 rpm) were culled and analyzed
using the Mann-Whitney test.
Quantitative reverse transcriptase polymerase chain
reaction (qRT-PCR) analysis
We used qRT-PCR to measure mRNA expression as
previously described [15,30,32]. In brief, cerebella were
homogenized in Qiazol reagent (Qiagen Inc., Valencia,
CA), and total RNA was isolated using the EZ1 RNA
universal tissue kit and the BIO Robot EZ1 (Qiagen,
Inc., Valencia, CA). RNA was reverse transcribed using
random oligodeoxynucleotide primers and the AMV
First Strand cDNA synthesis kit (Roche Diagnostics Cor-
poration, Indianapolis, IN). The resulting cDNA tem-
plates were used in qPCR amplification reactions with
gene specific primer pairs (Table 1) [32]. Primers were
designed using MacVector 10 software (MacVector, Inc.,
Cary, NC) and their target specificity was verified using
NCBI-BLAST (Basic Local Alignment Search Tool). The
amplified signals from triplicate reactions were detected
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ment and software (Eppendorf AG, Hamburg, Ger-
many). Relative mRNA abundance was calculated from
the ng ratios of specific mRNA to 18S rRNA measured
in the same samples. Inter-group statistical comparisons
were made using the calculated mRNA/18S ratios.
Enzyme linked immunosorbent assay (ELISA)
Cerebellar homogenates were prepared in radioimmuno-
precipitation assay (RIPA) buffer containing protease
and phosphatase inhibitors [30,33]. Protein concentra-
tions were determined using the bicinchoninic acid
(BCA) assay (Pierce, Rockford, IL). We performed direct
binding ELISAs to measure immunoreactivity. Samples
containing 50 ng protein diluted in Tris buffered saline,
pH 7.4 (TBS) were adsorbed to the bottom flat surfaces
of 96-well polystyrene plates (Nunc, Rochester, NY)
overnight at 4°C [18]. Non-specific binding sites were
blocked by a 3-hour room temperature incubation with
300 μl/well of TBS + 0.05% Tween 20 + 3% BSA. Sam-
ples were then incubated with 0.1-0.5 μg/ml primary
antibody for 1 h at 37°C. Immunoreactivity was detected
with horseradish peroxidase (HRP)-conjugated second-
a r ya n t i b o d ya n dA m p l e xR e ds o l u b l ef l u o r o p h o r e
(Molecular Probes, Eugene, OR) [18,33]. Fluorescence
was measured (Ex 530/Em 590) in a SpectraMax M5
microplate reader (Molecular Devices Corp., Sunnyvale,
CA). Parallel negative control assays had primary, sec-
ondary, or both antibodies omitted. Between steps, reac-
tions were rinsed 3 times with TBS + 0.05% Tween 20
using a Nunc ELISA plate washer.
Sources of reagents
QuantiTect SYBR Green PCR Mix was obtained from
(Qiagen Inc, Valencia, CA). Monoclonal antibodies to
Notch-1, Jagged-1, b-Actin and were purchased from
Abcam Inc. (Cambridge, MA). Antibodies to Hu, glial
fibrillary acidic protein (GFAP), myelin-associated glyco-
protein 1 (MAG-1), synaptophysin, SNAP-25, and GAP-
43 were purchased from Molecular Probes (Eugene,
OR), Santa Cruz Biotechnology Inc. (Santa Cruz, CA),
or Chemicon International (Tecumsula, CA). The 85G6
AAH mAb was generated to human recombinant pro-
tein and purified over Protein G columns (Healthcare,
Piscataway, NJ) [18].
Statistical analysis
Data depicted in the graphs represent the means ± S.E.
M.’s for each group. Inter-group comparisons were
made using Student t-tests since the siAAH and siScr
groups, and the pAAH and pGFP groups were studied
in separate experiments. Statistical analyses were per-
formed using the GraphPad Prism 5 software (San
Diego, CA) and significant P-values (<0.05) are indicated
over the graphs.
Results
Effects of siAAH on growth and brain weight
Rats were weighted on P2, P9, P21, and P35 (sacrifice)
and brain weights were obtained on P21 or P35.
Although initial body weights were similar for the two
groups, on P9 and P21, the siAAH-treated rats had sig-
nificantly lower mean body weights relative to siScr-
Table 1 Primer Pairs Used for Quantitative RT-PCR Analysis
Primers* Direction Sequence (5’®3’) Position (mRNA) Amplicon Size (bp)
Hu For CAC TGT GTG AGG GTC CAT CTT CTG 271 50
Hu Rev TCA AGC CAT TCC ACT CCA TCT G 320
MAG-1 For AAC CTT CTG TAT CAG TGC TCC TCG 18 63
MAG-1 Rev CAG TCA ACC AAG TCT CTT CCG TG 80
GFAP For TGG TAA AGA CGG TGG AGA TGC G 1245 200
GFAP Rev GGC ACT AAA ACA GAA GCA AGG GG 1444
Tau For CGC CAG GAG TTT GAC ACA ATG 244 65
Tau Rev CCT TCT TGG TCT TGG AGC ATA GTG 308
AAH For TGC CTG CTC GTC TTG TTT GTC 666 118
AAH Rev ATC CGT TCT GTA ACC CGT TGG 783
HES-1 For AGC GCT ACC GAT CAC AAA GT 70 143
HES-1 Rev TCA GCT GGC ATT TTC CTT TT 212
JAGGED-1 For CTG AGG ACT ACG AGG GCA AG 2041 191
JAGGED-1 Rev ACA GGT GAA TTT GCC TCC TG 2231
NOTCH-1 For GGT GGA CAT TGA CGA GTG TG 1918 204
NOTCH-1 Rev CCC TTG AGG CAT AAG CAG AG 2121
18S rRNA For GGA CAC GGA CAG GAT TGA CA 1278 50
18S rRNA Rev ACC CAC GGA ATC GAG AAA GA 1327
Forward (For) and reverse (Rev) primer pairs used to measure gene expression by qRT-PCR. Positions of the most 5’ nucleotides and the amplicon length (base
pair, bp) are listed.
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Page 3 of 13treated controls (Figure 1A). However, by P35, the mean
body weights were again similar for the two groups. On
P21, the mean brain weights were similar for siAAH-
and siScr-treated rats, but on P35, the siAAH-treated
rats had a slight, but significantly reduced mean brain
weight relative to controls (Figure 1B). In contrast,
intracerebroventricular transfection with pAAH pro-
duced no significant alterations in mean brain or body
weight relative to control (pGFP) (data not shown).
Rotarod test performance
The Rotarod test is used to assess sensorimotor coordi-
nation and provides a highly sensitive index of damage
to the cerebellum [34]. Rotarod test results were ana-
lyzed by grouping performance for Trials 1-3, 4-7, and
8-10, in which the rotation speeds were incremented
from 2 to 4.5, 5 to 7.5, and 8 to 10 rpm, respectively.
The mean ± S.E.M. latency to fall periods were calcu-
lated and results are depicted graphically with box plots
and minimum/maximum whiskers. For the earliest (low-
est speeds) set of trials, the siAAH and siScr-treated rats
performed similarly (Figure 2A). For the middle set of
trials, the siAAH-treated rats had a slightly shorter
mean latency to fall interval, but the difference from
control was not statistically significant (Figure 2B). The
largest inter-group difference was observed in the final
(most challenging) set of trials in which the siAAH trea-
ted rats had a significantly shorter mean latency to fall
interval relative to control (Figure 2C). In contrast, for
all 3 sets of trials, the pAAH-treated rats had signifi-
cantly longer mean latency to fall intervals compared
with the control group (Figures 2D,E,F).
Cerebellar hypofoliation in siAAH-treated rats
Cerebella from P21 rats were examined histologically.
Cerebella of siScr- (Figures 3A,D) and pGFP-transfected
(data not shown) control rats both exhibited long, thin,
regular folia with well-developed, slender white matter
cores, compact and densely populated granule and Pur-
kinje cell layers, and uniform molecular layers. In con-
trast, cerebella from siAAH-transfected rats had
relatively more shallow, blunted, broad, and irregular
folia with thick white matter cores (Figures 3B,E). In
addition, the granule cell layer was highly irregular in
thickness, and the Purkinje cell layer showed evidence
of on-going cell loss manifested by gaps, and shrinkage
and/or eosinophilia in many remaining neurons (Figure
3E). Cerebella of rats transfected with pAAH were histo-
logically similar to control, although they did exhibit
subtly increased complexity (less linear) within the gran-
ule cell layer, and greater variability in the depths of
sulci (grooving) (Figures 3C,F). Otherwise, the cell den-
sities and thickness of the cortical and white matter
layers were nearly indistinguishable from control.
Long-term effects of siAAH and pAAH on cellular gene
expression in cerebella
We used qRT-PCR analysis to examine expression of
cell profile genes corresponding to neurons (Hu and
tau), oligodendroglia (myelin-associated glycoprotein;
MAG-1), and astrocytes (glial fibrillary acidic protein;
GFAP) (Figures 4A, B, C, D, F, G, H, I). Results were
normalized to 18S rRNA levels measured in the same
s a m p l e s( F i g u r e s4 E , J ) .I np r e v i o u ss t u d i e s ,w eu s e dt h i s
approach to characterize cell loss and cell type shifts
associated with disease states [30,35,36]. The studies
demonstrated that siAAH treatment significantly
reduced the mean mRNA levels of Hu, Tau, MAG-1,
and GFAP relative to control (Figures 4A. B. C, D). In
contrast, the mean levels of 18S rRNA were similar in
Figure 1 Intracerebroventricular delivery of siAAH retards body
and brain growth. P2 Long Evans rat pups were administered
intracerebro-ventricular injections of siRNA targeting AAH (siAAH) or
no specific gene (siScr). Body weights were measured over the
course of the experiment, and brain weights were obtained at the
time of sacrifice. (A) Mean ± S.D. body weight measured on
postnatal days (P) 2, 9, 21, and 35. (B) Mean ± S.D. of brain weights
measured on P21 or P35. Inter-group statistical comparisons were
made using Student T-test analyses. N = 8-10 rats per group.
Significant P-values are provided above the graphs.
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Page 4 of 13Figure 2 Effects of siAAH and pAAH brain transfections on motor performance. P2 Long Evans rat pups were administered
intracerebroventricular injections of siRNA targeting AAH (siAAH) or no specific gene (siScr) (A-C), or recombinant plasmid DNA containing the
full-length AAH cDNA (pAAH) or GFP (D-F). On P20, rats were subjected to 10 incremental speed trials (from 2 to 10 rpm) of rotarod testing of
motor function. The maximum duration of performance was limited to 30 seconds. Data from (A, D) Trials 1-3 (2-4.5 rpm), (B, E) Trials 4-7 (5-7.5
rpm), and (C, F) Trials 8-10 (8-10 rpm) were culled and analyzed using the Mann-Whitney test. Panels display box plots with means and
minimum-maximum whiskers. Significant P-values are indicated within the panels.
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Page 5 of 13Figure 3 Intracerebroventricular siAAH impairs cerebellar development. Cerebella of rats treated by intracerebroventricular injections of
siAAH, siScr, pAAH, or pGFP were harvested on P21, sectioned in the mid-sagittal plane, fixed in Histochoice, and embedded in paraffin.
Histological sections were stained with LHE. (A-C) Low (100×) and (D-F) high (600×) magnification images of cerebella from (A, D) siScr, (B, E)
siAAH, or (C, F) pAAH injected rats. Note long, thin, regular folia with well-developed, slender white matter (wm) cores, compact and densely
populated granule (gcl) and Purkinje (PC) cell layers in cerebella of siScr- and pAAH-transfected rats, compared with the more shallow, blunted,
broad, and irregular folia, thick white matter cores, irregular thickness of the granule cell layer, and neuronal loss or neuronal atrophy in the
Purkinje cell layer (arrows) in cerebella of siAAH-transfected rats. (C) Cerebella of pAAH-transfected rats displayed only subtle differences from
siScr or pGFP (not shown) controls in that the granule cell layer was somewhat less linear due to slightly increased architectural complexity
(C; arrows). The molecular layer (ml) of the cerebella were similar in all groups.
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Page 6 of 13Figure 4 Effects of AAH inhibition or over-expression on cell type specific gene expression. P2 Long Evans rat pups were administered
intracerebroventricular injections of (A-E) siAAH or siScr, or (F-J) recombinant plasmid pAAH or pGFP cDNA. Cerebellar tissue harvested from P21
rats was used to measure mRNA levels of (A, F) Hu, (B, G) tau, (C, H) GFAP, and (D, I) MAG-1, and (E, J) 18S rRNA by qRT-PCR. The graphs in
Panels A-D and F-I depict calculated mRNA/18S ratios, and those in Panels E and J represent the mean ng rRNA input into the reactions. Panels
display box plots with means and minimum-maximum whiskers. Inter-group statistical comparisons were made using Student T-tests. Significant
P-values are indicated within the panels.
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Page 7 of 13siAAH-treated and siScr control brains (Figure 4E).
Brains transfected with pAAH had significantly higher
mean levels of tau, and reduced expression of GFAP
mRNA, but unaltered mean levels of Hu, MAG-1, and
18S relative to pGFP-transfected controls (Figures 4F, G,
H, I, J).
Effects of siAAH and pAAH on downstream notch
signaling mechanisms
Previous studies demonstrated that AAH protein inter-
acts with and hydroxylates Notch and Jagged, leading to
increased Notch signaling and expression of down-
stream target genes such as HES-1 [15]. Moreover, we
previously demonstrated that intracerebral injection of
young rat pups with recombinant plasmid DNA, when
complexed with reagents used for in vitro transfection,
can significantly and selectively increase gene expression
throughout the brain and in all cell types, and with
effects sustained for several weeks [29]. In both the for-
mer and current study, we monitored GFP expression,
and effects of targeted gene inhibition with siRNA in
brain by qRT-PCR analysis. In the present study, qRT-
PCR analyses demonstrated that siRNA inhibition of
AAH significantly reduced the mean cerebellar mRNA
levels of AAH (Figure 5A) and HES-1 (Figure 5D), but
had no significant effects on the mean mRNA levels of
Notch-1 (Figure 5B) or Jagged-1 (Figure 5C) relative to
siScr-transfected controls. In contrast, brains transfected
with pAAH had significantly higher mean cerebellar
levels of AAH (Figure 5E) and HES-1 (Figure 5H)
mRNA, but similar levels of Notch-1 (Figure 5F) and
Jagged-1 (Figure 5G) relative to pGFP-transfected
controls.
ELISA studies further demonstrated that the siAAH
treatments significantly reduced mean levels of AAH
and Notch-1 protein, and increased Jagged-1, the ligand
of Notch, but had no significant effect on the mean
level of b-actin (Figures 6A, B, C, D). Transfection with
pAAH significantly increased the mean levels of AAH,
Notch-1 and Jagged-1 proteins, but did not significantly
alter b-actin immunoreactivity relative to pGFP-trans-
fected control cerebella (Figures 6E, F, G, H). Given the
effects of siAAH and pAAH intracerebroventricular
transfections on cerebellar structure and function, we
entertained the hypothesis that AAH may impact
synapse formation and plasticity. Therefore, we extended
the analyses to measure 3 synaptic proteins, i.e. synapto-
physin, which mediates synaptic communication
[37], synaptosome-associated protein of 25 kD (SNAP-
25), which is essential for calcium-dependent vesicle
exocytosis [38], and growth-associated protein, 43 kD
(GAP-43), which plays a role in neurite formation and
plasticity [39]. We also measured GFAP immunoreactiv-
ity as an index of astrocyte function or activation.
Those investigations demonstrated that both siAAH and
pAAH transfections significantly decreased GFAP
immunoreactivity in cerebella (Figures 6I,M). In addi-
tion, siAAH transfection slightly, but significantly,
increased synaptophysin and SNAP-25 immunoreactivity
(Figures 6J,L). In contrast, pAAH transfection had no
significant effect on the mean levels of synaptophysin or
SNAP-25, and neither siAAH nor pAAH significantly
altered the mean levels of GAP-43 (Figure 6). Therefore,
it appears that inhibition or over-expression of AAH by
intracerebroventricular transfection mainly impacts cere-
bellar foliation and neuronal migration, while minimally
influencing synaptic processes.
Discussion
This study investigated the role of AAH in cerebellar
development and function. The goal was to determine
the degree to which ethanol’s inhibition of AAH expres-
sion contributes to FASD-associated structural and
functional abnormalities in the cerebellum. We demon-
strated that intracerebroventricular transfection with
siAAH significantly impairs motor function, while over-
expression of AAH in the cerebellum enhances motor
performance as demonstrated by rotarod testing. Impor-
tantly, although the siRNA and recombinant plasmid
DNA transfections were performed on P2, the CNS
effects persisted for several weeks, corresponding with
results in a previous report utilizing this same experi-
mental approach [29].
The siAAH-induced impairments in motor function
were associated with conspicuous structural abnormal-
ities in the cerebellum, including reduced foliation and
decreased expression of genes that mark neurons (Hu),
astrocytes (GFAP), and oligodendroglia (MAG-1). In
addition, siAAH brain transfections reduced tau and
GFAP expression. Together, these findings suggest that
siRNA-mediated inhibition of AAH expression during
postnatal cerebellar development results in net losses of
neurons, oligodendroglia, and astrocytes. Since tau and
GFAP represent major cytoskeletal proteins expressed in
neurons and astrocytes, respectively, inhibition of AAH
could promote cytoskeletal collapse and reduced inter-
cellular connectivity and signaling, irrespective of rela-
tively preserved or marginally reduced expression of
synaptic plasticity proteins, including SNAP-25 and
synaptophysin [37-39]. On the other hand, the signifi-
cantly improved motor function and increased expres-
sion of tau associated with pAAH transfection indicate
that robust AAH expression in the cerebellum during
the early postnatal period could have a positive impact
on subsequent cerebellar development and motor func-
tion. Therefore, ethanol’s inhibition of AAH in the
developing cerebellum most likely contributes to the
cerebellar motor deficits in FASD.
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Page 8 of 13Figure 5 Inhibition or over-expression of AAH modulates Notch signaling mechanisms. P2 Long Evans rat pups were administered
intracerebroventricular injections of (A-D) siAAH or siScr, or (E-H) recombinant plasmid pAAH or pGFP cDNA. Cerebellar tissue harvested from
P21 rats was used to measure mRNA levels of (A, E) AAH, (B, F) Notch-1, (C, G) Jagged-1, and (D, H) HES-1 by qRT-PCR, with results normalized to
18S rRNA (Figures 4E, 4J). Panels display box plots with means and minimum-maximum whiskers. Inter-group statistical comparisons were made
using Student T-tests. Significant P-values are indicated within the panels.
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Page 9 of 13The adverse effects of siAAH on cerebellar structure
and function are highly reminiscent of previous findings
in experimental models of FASD [18,25,27]. In particu-
lar, chronic gestational exposure to ethanol results in
reduced cerebellar foliation with loss of neurons and oli-
godendrogial cells, and reduced expression of neuronal
cytoskeletal proteins [18,25,27]. Moreover, ethanol expo-
sure during development impairs motor performance
due to cerebellar hypoplasia. Since AAH has a demon-
strated role in mediating cell migration, which is needed
for proper cerebellar foliation, reduced AAH expression
in brains of siAAH-transfected rats could account for
the associated perturbations in cerebellar architecture.
Therefore, ethanol’s inhibition of insulin/IGF stimula-
tion of target genes, e.g. AAH, that mediate neuronal
motility, contributes to some of the major CNS terato-
genic effects of ethanol, including reduced cerebellar
foliation and function. The adverse effects of siAAH
were much less severe than those caused by early expo-
sure to ethanol during development [18,25,27], perhaps
because ethanol inhibits expression and function of
many genes regulated by insulin/IGF signaling pathways,
whereas siAAH targets just one of those genes and its
downstream signaling through Notch [15].
Previous studies demonstrated that AAH mediates its
effects on cell motility by interacting with, and hydroxy-
lating Notch and Jagged [7], and that a downstream tar-
get of Notch signaling is the effector gene, HES-1
[40,41]. Since Notch-1 stimulates HES-1 transcription
[42], the reductions in HES-1 mRNA caused by siAAH
support the notion that Notch signaling is regulated by
AAH. As demonstrated herein, and in previous reports,
over-expression of AAH increases Notch-1 protein
levels and HES-1 gene expression [15]. Previously, we
Figure 6 Long term effects of siAAH and pAAH intracerebroventricular transfection on Notch signaling and plasticity proteins. P2 Long
Evans rat pups were administered intracerebroventricular injections of (A-D; I-L) siAAH or siScr, or (E-H; M-P) recombinant plasmid pAAH or pGFP
cDNA. Cerebellar tissue harvested from P21 rats was used to measure immunoreactivity to (A, E) AAH-A85G6 antibody, (B, F) NOTCH-1, (C, G)
Jagged-1, (D, H) b-actin, (I.M) GFAP, (J, N) synaptophysin, (K, O) GAP-43, and (L, P) SNAP-25 by direct binding ELISA. Immunoreactivity was
detected with horseradish peroxidase conjugated secondary antibody and the Amplex Red fluorophore. Fluorescence was measured in a
Spectramax M5 microplate reader (Ex 530 nm/Em 590 nm). Panels display box plots with means and minimum-maximum whiskers. Inter-group
statistical comparisons were made using Student T-tests. Significant P-values are indicated within the panels.
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Page 10 of 13showed that AAH over-expression stimulates Notch’s
translocation to the nucleus where it regulates gene
expression [15]. Once in the nucleus, Notch-1 serves as
a transcription factor for other genes involved in various
functions, including motility.
Since siAAH and pAAH transfections had no signifi-
cant effects on Notch’s mRNA levels, AAH’s regulation
of Notch is likely mediated by post-translational
mechanisms. For example, AAH hydroxylation of Notch
leading to its translocation to the nucleus reflects post-
translational regulation of Notch protein. Jagged is a
ligand for Notch, and its binding to Notch is needed for
Notch cleavage and release from the membrane for
translocation to the nucleus [13,43,44]. The finding that
pAAH increased Jagged-1 protein expression suggests
an additional mechanism by which AAH regulates
Notch signaling. The relevance of this observation is
that Jagged and Notch are known to play critical roles
in neuronogenesis and gliogenesis, and in maintaining
the specialized functions of oligodendrocytes and radial
glia [45-50]. Since oligodendrocytes produce central ner-
vous system myelin and radial glia are needed for proper
neuronal migration and organization of the cerebellar
cortex [51,52], the impaired cerebellar foliation coupled
with significantly reduced expression of Hu, MAG-1
and GFAP in siAAH-transfected brains correlate with
the associated inhibition of Notch and HES-1 expres-
sion/signaling. Furthermore, siAAH may also have
mediated its adverse effects on cerebellar structure by
interfering with Notch signaling through sonic hedgehog
[53], as sonic hedgehog mediates cerebellar foliation
[54]. While all of the effects of siAAH or pAAH cannot
be explained readily, conceivably some of the responses
were either compensatory or regulated by yet unknown
mechanisms involving pathways affected by AAH but
not investigated herein.
Conclusions
Together, these studies demonstrate a pivotal role for
AAH in cerebellar development, structure, and function,
and confirm that AAH expression is integrally tied to
Notch-Jagged-HES-1 signaling, which regulates target
genes that mediate neuronal migration and cerebellar
cortical foliation in the brain. Moreover, the findings
herein support the concept that ethanol inhibition of
AAH expression during development mechanistically
contributes to the cerebellar dysgenesis, and attendant
impairments in motor function.
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